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Abstract
Background: The 3'-untranslated region (3'-UTR) of mRNA contains regulatory elements that
are essential for the appropriate expression of many genes. These regulatory elements are involved
in the control of nuclear transport, polyadenylation status, subcellular targetting as well as rates of
translation and degradation of mRNA. Indeed, 3'-UTR mutations have been associated with disease,
but frequently this region is not analyzed. To gain insights into congenital heart disease (CHD), we
have been analyzing cardiac-specific transcription factor genes, including GATA4, which encodes a
zinc finger transcription factor. Germline mutations in the coding region of GATA4 have been
associated with septation defects of the human heart, but mutations are rather rare. Previously, we
identified 19 somatically-derived zinc finger mutations in diseased tissues of malformed hearts. We
now continued our search in the 609 bp 3'-UTR region of GATA4 to explore further molecular
avenues leading to CHD.
Methods: By direct sequencing, we analyzed the 3'-UTR of GATA4 in DNA isolated from 68
formalin-fixed explanted hearts with complex cardiac malformations encompassing ventricular,
atrial, and atrioventricular septal defects. We also analyzed blood samples of 12 patients with CHD
and 100 unrelated healthy individuals.
Results: We identified germline and somatic mutations in the 3'-UTR of GATA4. In the malformed
hearts, we found nine frequently occurring sequence alterations and six dbSNPs in the 3'-UTR
region of GATA4. Seven of these mutations are predicted to affect RNA folding. We also found
further five nonsynonymous mutations in exons 6 and 7 of GATA4. Except for the dbSNPs, analysis
of tissue distal to the septation defect failed to detect sequence variations in the same donor, thus
suggesting somatic origin and mosaicism of mutations. In a family, we observed c.+119A > T in the
3'-UTR associated with ASD type II.
Conclusion: Our results suggest that somatic GATA4 mutations in the 3'-UTR may provide an
additional molecular rationale for CHD.
Published: 25 June 2007
BMC Medical Genetics 2007, 8:38 doi:10.1186/1471-2350-8-38
Received: 16 November 2006
Accepted: 25 June 2007
This article is available from: http://www.biomedcentral.com/1471-2350/8/38
© 2007 Reamon-Buettner et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
Page 2 of 12
(page number not for citation purposes)
Background
GATA4 (MIM# 600576) is a transcription factor which is
characterized by a highly conserved binding domain of
two zinc fingers. It is expressed in the heart and is essential
for mammalian cardiac development (see reviews [1-3]).
In mice, germline ablation of the gene encoding Gata4
results in abnormal ventral folding of the embryo, failure
to form a single ventral tube, and lethality [4,5]. Besides
heart development, Gata4 is involved in the formation of
multiple organs, such as intestine, liver, pancreas and
swim bladder in zebrafish [6] as well as gastric epithelial
development in mouse through interaction with Fog co-
factors [7].
In humans, four GATA4 gene mutations have been iden-
tified in families with congenital heart defects (CHD)
notably, atrial septal defects [8-11]. One mutation
(p.Gly296Ser) affects a highly conserved amino acid after
the C-terminal zinc finger, and disrupts physical interac-
tion with TBX5 [8], a transcription factor described to be
defective in Holt-Oram syndrome [12]. But GATA4 germ-
line mutations are rather rare. Two studies analyzed 16
families each, but only 2/16 families with multiple
affected members carried GATA4 mutations [10,11]. In 42
patients with non-syndromic atrioventricular septal
defects (familial as well as sporadic), no GATA4 muta-
tions have been detected [13].
It is of considerable importance that genetic analysis of
blood samples may not reveal somatically-occurring
sequence alterations in the diseased cardiac tissues, but
these mutations may provide a molecular rationale for
pathogenesis [14,15]. We recently reported evidence for
somatically-derived  NKX2-5  and  TBX5  mutations as a
novel mechanism for septation defects of the human
heart [16-18], and used the same heart collection of mal-
formed hearts to investigate GATA4 gene mutations, nota-
bly those affecting the coding of amino acids for zinc
finger functions of the protein [19]. To identify further
genetic alterations associated with CHD, we continued
our search in the 609 bp of 3'-untranslated region (3'-
UTR) of GATA4.
The 3'-UTR of GATA4 is relatively long and likely contains
regulatory elements essential for the regulation and trans-
port of the mRNA transcript [20]. Indeed, evidence is
accumulating that the 3'-UTR of mRNA is involved in the
control of nuclear transport, polyadenylation status, sub-
cellular targetting as well as rates of translation and degra-
dation of mRNA; thus sequence alterations in this region
may lead to disease (see review [21,22]). Recently, a single
nucleotide deletion in the 3'-UTR of high mobility group
A1 gene (HMGA1) was identified in two type 2 diabetes
patients exhibiting deficiency of the protein [23]. The
mutation decreased HMGA1 mRNA half life in the lym-
phoblast cells of the patients, and further deletion of the
3'-UTR of HMGA1  resulted in the decrease of reporter
assay expression. To the best of our knowledge, the 3'-UTR
of GATA4 has not been investigated particularly as regards
its role in post-transcriptional gene expression. In this
paper, we report the detection of frequent GATA4
sequence alterations in the 3'-UTR in the diseased tissues
of malformed hearts, some of which are predicted to alter
RNA secondary structure. As a result of aberrant RNA fold-
ing, these mutations may lead to CHD by affecting mRNA
localization and translation of protein. We found further
five nonsynonymous mutations in exons 6 and 7 of
GATA4.
Results
GATA4 is located on chromosome 8p23.1-p22, consists of
seven exons and codes for a 442- amino-acid protein (see
Fig. 1A). We investigated the genomic DNA for sequence
variations in the entire coding region and untranslated
regions (UTR) of this gene. In the case of formalin-fixed
material, exons 3, 4, 6 and 7 of malformed hearts of
patients with complex CHD could be amplified. We
reported earlier the detection of 23 nonsynonymous
mutations in exons 3 and 4, notably mutations affecting
the zinc fingers of GATA4 [19]. Here we report further five
nonsynonymous mutations in exons 6 and 7, which affect
highly conserved amino acids 361, 377, 430, 432 and 442
in the C-terminal region of GATA4 (Table 2). Whether
these sequence alterations result in aberrant protein
expression requires additional studies. Previously, it has
been shown that a frameshift mutation past amino acid
359 severely altered the encoded GATA4 protein and was
associated with ASD [8]. Nonetheless, mutations
p.Leu432Ser and p.Ala442Thr identified by us would
affect polarity of the protein, due to replacement of non-
polar, hydrophophic amino acids with polar, hydrophilic
ones. In addition, p.Met361Val likely results in aberrant
RNA folding, as determined by a method described
below.
Notably, exon 7 of GATA4 consists of 1,708 bp, the major-
ity (1,525 bp) being untranslated. From our collection of
formalin-fixed hearts, we could amplify the first four frag-
ments of exon 7 (see Fig. 1A and Table 1 for the primer
sequences designated GTx7-1 to GTx7-4). These primer
sequences cover a part of the coding region c.1221 to
c.1329 (nt 1739–1847, NM_002052) and 3'-UTR from
c.+1 to c.+609 (nt 1848–2456, NM_002052). We found 9
sequence alterations, occurring in 3 to 7 patients, and 6
dbSNPs in the analyzed 3'-UTR region of GATA4 (Table 2,
Table 3). On the basis of sequence electropherograms
and/or PCR-RFLP assays, both heterozygous and
homozygous genotypes were observed (Fig. 1B). Using
the program GeneQuest (Lasergene 6.0), we determined
the effect of the nine sequence alterations on RNA folding.BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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GeneQuest uses the Vienna RNA folding procedure, taken
from Zuker's optimal RNA folding algorithm, to fold the
sense strand of selected DNA regions as RNA. We investi-
gated the first 500 bp of the 3'-UTR, simply because the
sequence alterations identified by us are located within
this segment. Furthermore, there is suggestion that the
whole 3-'UTR is not necessary for localization, but that
localization signals lie within the regions of < 100–200 nt
[25]. Compared to the reference sequence, 7/9 of these
would result in faulty RNA folding (Fig. 2). While c.+77C
> T and c.+479A > G would likely not lead to faulty RNA
folding, the same pattern was observed for c.+10T > C and
c.+44T > A. In addition, we searched the 3'-UTR of GATA4
for highly conserved motifs that may be involved in post-
transcriptional regulation, (see [26]). None of the con-
served motifs reported so far have been detected, but the
highly conserved motif (AATAAA) associated with polya-
denylation signals were located at positions c.+678–683
and c.+1502–1507.
To compare healthy vs. diseased tissues from each patient,
we selected specifically those who were positive for muta-
tions in the diseased tissue. For instance, in the diseased
tissues, we found 17/68 patients without nucleotide
changes in analyzed region of the 3'-UTR except for the
dbSNPs. Thus for this comparison, we analyzed 21
patients for GTx7-1 (21 × 2 × 289 bp = 12,138 nucleo-
tides); 25 patients for GTx7-3 (25 × 2 × 281 bp = 14,050
nucleotides) and 24 patients for GTx7-4 (24 × 2 × 270 bp
= 12,960 nucleotides). Except for the dbSNPs rs867858,
rs1062219, rs884662, rs904018, rs12825 (see Table 2),
none of the mutations were detected in the unaffected tis-
Genetic analysis of GATA4 Figure 1
Genetic analysis of GATA4. (A) Schematic representation of GATA4 (genomic, mRNA and protein level). Reference sequence 
for GATA4 was based on NM_002052 and the intron-exon boundaries on [42]. (B) Examples of 3'-UTR mutations and geno-
types obtained after direct sequencing of fragments amplified from diseased cardiac tissues of patients affected by CHD. Addi-
tional sequence alterations in the 3'- UTR of GATA4 were detected, e.g. F24ASD (c.+281G>A).BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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sues. This result suggests somatic origin and mosaicism of
mutations.
In the formalin-fixed malformed hearts, we observed six
dbSNPs which were all located within 234 nucleotides in
exon 7 (Table 2). We could calculate the allele frequencies
for five loci (Table 2) and found the dbSNPs to be in
Hardy-Weinberg equilibrium. We cloned three fragments
from hearts heterozygous for rs1062219 (c.+426C > T),
rs884662 (c.+517T > C) and rs904018 (c.+532T > C). Sur-
prisingly, we found three haplotypes after sequencing of
at least four clones in each heart. In all three hearts, we
found one type containing all reference alleles [c.+426C;
c.+517T; c.+532T] and another type with all variant alleles
[c.+426T; c.+517C; c.+532C]. Additional types found
were [c.+426T; c.+517T; c.+532T] with one variant allele,
and [c.+426C; c.+517C; c.+532C] with two variant alleles.
We further analyzed the entire gene in blood samples of
12 patients with CHD (see Fig. 1A). Mostly dbSNPs were
detected (Table 4); nonetheless we observed two sequence
variations in the 3'-UTR (c.+119A > T and c.+1260G > A)
and two intronic (c.-518-25C > T and c.-458+5A > G)
which have not yet been reported as dbSNPs. The 3'-UTR
alterations and c.-518-25C>T were detected in a family of
four, in which the two children were affected by ASD, but
the parents had no history of CHD. For c.+119A>T, the
mother was homozygous for the reference allele AA, while
the father and the children had the heterozygous genotype
AT (Fig. 3A&B). This sequence variation would affect RNA
folding (Fig. 3C). As control, we analyzed blood samples
from 100 unrelated Caucasian healthy individuals. No
sequence variations were found, except for a synonymous
change in exon 3 (c.699G>A, p.233Thr), an intronic
(c.783+16G>A) and dbSNPs (Table 4).
Discussion
Recent studies characterize further the importance of
Gata4 in cardiac development. Indeed, small changes in
the level of Gata4 protein expression can dramatically
influence cardiac morphogenesis and embryonic survival
[27]. Moreover, myocardial expression of Gata4  is
required for proliferation of cardiomyocytes, formation of
the endocardial cushions, development of the right ventri-
cle, and septation of the outflow tract [28]. To gain further
insights into the role of GATA4  mutations in CHD in
humans, we have analyzed the Leipzig collection of mal-
formed hearts for sequence alterations of this gene. We
reported previously the identification of 23 nonsynony-
mous mutations, 19 of which are located within the
highly conserved zinc fingers and basic regions of GATA4
[19]. Notably, we identified a frequent mutation
(p.Cys292Arg) in VSDs, which affects one of the four zinc
coordinating cysteines in the C-finger and is predicted to
Table 1: Primer sequences and PCR conditions used for analysis of GATA4 mutations
GATA4 exons Exon size (bp) Primer Primer length Primer sequence (5'-3') Melting temperature PCR product length (bp)
exon 1 61 GT4x1F 20 cttgcacgtgactcccacag 65°C 250
GT4x1R 20 aagcaaaggcggagaagctc
exon 2 1073 GT4x2-1F 21 tctctttctgtcgttcctctt 65°C 600
GT4x2-1R 20 gcacgtagactggcgaggac
GT4x2-2F 21 ggaccatgtatcagagcttgg 65°C 641
GT4x2-2R 20 gccctcgcgctcctactcac
exon 3 167 GT4x3F 24 agtcagagtgaggaagagcaagag 65°C 541
GT4x3R 21 cagtttctgtgtgccgaagag
exon 4 126 GT4x4F 20 ccagccctgcctcccgttag 65°C 294
GT4x4R 23 gaggactgagagatgggcatcag
exon 5 88 GT4x5F 22 agtagccatcacatcacacagg 65°C 504
GT4x5R 19 aaagctcccaacacgttcc
exon 6 149 GT4x6F 20 gtttgtccctgccgctgatt 65°C 247
GT4x6R 20 gcagtcggcctccccacaaa
exon 7 1708 GTx7-1F 19 acaaggctatgcgtctccc 60°C 289
GTx7-1R 20 ctgagaaaatccaacacccg
GT4x7-2F 20 gcgtaatcttccctcttccc 65°C 291
GT4x7-2R 19 gggacaaggacatcttggg
GTx7-3F 20 gtcgacaatctggttagggg 60°C 281
GTx7-3R 20 gtacatggcaaacagatgcc
GTx7-4F 20 gaggatctgagaacaagcgg 60°C 270
GTx7-4R 20 cagctgcattttgatgaggc
GTx7-5F 22 aaattgtggggtgtgacataca 60 °C 577
GTx7-5R 22 gttgcagaatctctggcttttt
GTx7-6F 22 ctgtctgtctgctcctcctagc 65°C 586
GTx7-6R 22 acctcccagtgaagaccactaaBMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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disrupt the secondary structure of the protein. Functional
characterization of site-directed mutated residues in the
C-finger, showed that disruption of the zinc coordinating
cysteines, would abolish DNA binding, Gata4-Nkx2-5
interactions and synergy [29,30].
To identify genetic alterations associated with CHD, we
continued our search for mutations in the 3'-UTR region
of GATA4. In the diseased tissues of malformed hearts, we
found frequent alterations in the 3'-UTR of GATA4, in
which 7/9 would affect RNA folding. Additional sequence
alterations in the 3'- UTR of GATA4 were detected, but
these were mostly isolated cases and therefore not
reported here. Further, we identified a germline mutation
(c.+119A>T) in which two affected family members were
positive. Similarly, it would alter RNA folding. Since the
unaffected father carried c.+119A>T, we cannot discount
the possibilities of a low penetrance mutation or no causal
association at all. Whether the 3'-UTR mutations reported
here contributed to cardiac malformations by affecting
the secondary structure of mRNA or through other post-
transcriptional regulation associated with 3'-UTR,
requires further functional analysis. Nonetheless, it has
been shown that two mutations in the 3'-UTR of rat Mti
(metallothionein-1) that are predicted to alter the second-
ary structure of this region also impaired localization of
the mRNA [25].
There is, however, accumulating evidence on the impor-
tant role of 3'-UTR in post-transcriptional regulation. For
instance, efficient termination and stability of mRNA are
dependent on a properly configured 3'-UTR [31]. Locali-
zation of mRNAs is also due to specific sites or signals
within the 3'-UTR [25,32]. Recently, a systematic search
discovered 106 highly conserved motifs in human 3'-
UTRs that may be involved in post-transcriptional regula-
tion, including mRNA stability and degradation [26].
Many of these are associated with microRNAs, which are
non-coding RNAs of 21–22 nucleotides and are comple-
mentary to the 3'-UTR motifs that mediate post-transcrip-
tional regulation [33]. Similary, 53 sequence motifs have
been catalogued in 3'-UTR of yeast mRNAs, including
motifs corresponding to known RNA-binding protein
sites and motifs associated with subcellular localization
[34]. Furthermore, 83 disease-associated variants in the 3'-
UTR of human protein-coding genes have been systemat-
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1599 c.1081A>G p.Met361Val exon 6 1 1
1648 c.1130G>A p.Ser377Asn exon 6 1 1
1806 c.1288C>G p.Leu430Val exon 7 1 1 2
1813 c.1295T>C p.Leu432Ser exon 7 1 1
1842 c.1324G>A p.Ala442Thr exon 7 1 1
3'UNTRANSLATED REGION
1857 c.+10T>C exon 7 1 2 4 7 EarlI
1891 c.+44T>A exon 7 1 3 4
1924 c.+77C>T exon 7 2* 3* 5 Styl
2065 c.+218C>T exon 7 1 3 4 EarlI
2106 c.+259A>G exon 7 1 1 2* 4
2127 c.+280T>C exon 7 1 3* 1 5
2289 c.+442A>G exon 7 1 1 1 3
2309 c.+462T>C exon 7 1 4 1 6
2326 c.+479A>G exon 7 1* 1 1 3 NarI
2201 c.+354A>C exon 7, 
dbSNPrs867858
27AA:2AC 12AA:4AC 19AA:3AC:1CC 58AA:9AC:1CC MspA1I
2273 c.+426C>T exon 7, 
dbSNPrs1062219
1CC:8CT:20TT 2CT: 13TT 1CC: 4CT:18TT 2CC:14CT:51TT
2364 c.+517T>C exon 7, 
dbSNPrs884662
9TT:16CT:4CC 4TT:11CT 4TT:15CT:4CC 17TT:42CT:8CC
2379 c.+532T>C exon 7, 
dbSNPrs904018
1TT:9CT:19CC 9CT:6CC 1TT:3CT:19CC 2TT:21CT:44CC
2410 c.+563C>G exon 7, 
dbSNPrs12825
15CC:8CG:6GG 2CC:12CG 15CC:6CG:2GG 32CC:26CG:8GG
2434 c.+587A>G exon 7, 
dbSNPrs804291
1AG:28GG 13GG 23GG 1AG:64GG
* homozygous genotypes observed
** nonsynonymous mutations in exons 3 and 4 reported earlier (Reamon-Buettner and Borlak, J Med Genet 42:e32)BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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Table 3: Spectrum of GATA4 mutations (nonsynonymous and 3'-UTR) in diseased tissues of malformed hearts
Patient Age Total defects* Detected mutations
Coding (ns)*** 3'-UTR Total
VSDs
C06VSD** 1h 3 F211L, Y244C, R260Q, C292R 4
C10VSD stillborn 6 C292R 1
C19VSD 3 mo 4 C292R 1
C58VSD 18 d 5 C292R c.+77C>T 2
D01VSD aborted 3 C292R 1
D03VSD 2 mo 4 C292R 1
E03VSD** 6 mo 2 c.+77C>T 1
E04VSD** 5 wk 2 C292R 1
E08VSD 53 yr 1 C292R 1
E10VSD 6 mo 4 G214S 1
E11VSD newborn 1 c.+10T>C 1
E13VSD 16 yr 1 N239S, C292R 2
E15VSD 8 mo 2 N239D 1
E16VSD 3 mo 3 M361V 1
E20VSD 2 d 3 0
E22VSD 4 mo 3 F208L, C292R 2
E23VSD** 22 d 3 L261P, C292R 2
E26VSD 6 mo 3 C292R, S377N c.+479A>G 3
E27VSD 5 mo 2 M223T, R229S, C292R c.+462T>C 4
E28VSD 5 mo 2 c.+44T>A 1
E29VSD 8 wk 3 C292R 1
E31VSD 5 mo 2 0
E33VSD 14 yr 1 A442T 1
E34VSD 3 mo 2 0
E35VSD 4.5 mo 2 C292R 1
E39VSD 9 mo 3 C292R c.+218C>T, c.+259A>G 3
E40VSD 15 mo 1 C292R 1
E41VSD 23 yr 2 C292R c.+280T>C 2
E49VSD newborn 3 C292R c.+442A>G 2
ASDs
C09ASD 26 yr 2 0
C39ASD 25 yr 4 C292R 1
C45ASD 6 d 7 C292R, L432S c.+280T>C, c.+462T>C 4
C46ASD 34 yr 3 C292R c.+10T>C, c.+259A>G, c.+462T>C 4
C64ASD 11 mo 4 C292R 1
C75ASD 2 mo 6 C292R 1
D30ASD 11 yr 3 L430V 1
D33ASD 8 yr 2 N248S, L261P c.+462T>C, c.+479A>G 4
F17ASD 4 1/2 h 1 c.+280T>C 1
F19ASD 8 yr 4 c.+462T>C 1
F20ASD 10 yr 1 0
F24ASD 6 yr 3 c.+280T>C 1
27ASD 7 yr 2 C292R c.+442A>G 2
F29ASD 14 yr 8 I255T, A294V c.+10T>C 3
F30ASD 1 d 2 0
F32ASD 38 yr 1 R229S 1
AVSDs
C43AVSD 10 mo 7 H302R c.+10T>C 2
C70/2AVSD** 8 mo 6 G234S, R252P, C292R 3
C71AVSD** 4 d 5 c.+10T>C, c.+442A>G 2
E05AVSD 16 wk 6 c.+10T>C 1
E36AVSD** 3.5 mo 4 0
E43AVSD 4.5 mo 4 R283H 1
F00AVSD** 6 wk 5 c.+44T>A, c.+218C>T 2
F02AVSD 10 mo 7 N248S c.+77C>T 2
F03AVSD** 1 mo 4 c.+44T>A 1BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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ically analyzed, and that functionality of these variants
correlated highly to predicted secondary structural
changes [35].
Many studies are suggestive for Gata4 to network with
other transcription factors to regulate cardiac gene expres-
sion (see reviews [1-3]). These protein-protein interac-
tions are mediated through the proteins' binding domains
and for Gata4, the zinc fingers are involved. For instance,
N-terminal zinc finger interacts with Fog2, while the C-
terminal zinc finger contacts Nkx2-5, Nf-At3, Mef2c and
Hand2. Notably, the C-finger of Gata4 interacts with the
third alpha helix (homeodomain) of Nkx2-5, to enable
transcriptional synergy of regulated genes. Site-directed
mutagenesis of zinc coordinating cysteines in the C-finger
leads to abrogation of Gata4-Nkx2-5 interaction and loss
of synergy [29,30]. We reported previously the identifica-
tion of somatically-derived GATA4 zinc finger mutations
in the same malformed hearts, including a frequent muta-
tion (p.Cys292Arg) in VSDs, which affects one of the four
zinc coordinating cysteines and is predicted to disrupt the
secondary structure of the protein [19]. However, aside
from p.Cys292Arg and unlike NKX2-5 [16,17] common
nonsynonymous mutations are rare in the coding regions
of GATA4. Thus, the further detection of mutations in the
3'-UTR of GATA4 in the same malformed hearts with zinc
finger mutations suggests a possible further mechanisms
of disease, in which the zinc fingers are not involved.
Indeed, as shown in Table 3, in which GATA4 nonsynon-
ymous and 3'-UTR mutations identified in hearts with
septation defects are summarized, there were 14 with 3'-
UTR mutations only. These consist of 3 in VSDs, 3 in
ASDs, and 8 in AVSDs. From these 14 hearts, 12 carried 3'-
UTR mutations that are predicted to result in aberrant
RNA folding. As can be surmised from Table 3, it appears
that 3'-UTR mutations are more frequent in ASDs and
AVSDs than in VSDs. In VSDs, 23 out of 29 had mutations
in the coding region, most of which were p.Cys292Arg
and only 9 out of 29, carried 3'-UTR mutations. It is also
of considerable interest that sporadic cases of CHD from
Lebanese population were analyzed for mutations affect-
ing the zinc fingers and basic region of GATA4 [36]. A
mutation (p.Glu216Asp) in the N-terminal zinc finger
was detected in 2/26 patients with Tetralogy of Fallot
(TOF), and this mutation resulted in reduced transcrip-
tional activity without affecting GATA4's ability to bind
DNA, nor its interaction with ZFPM2 (FOG2). However,
none of the other 94 patients with various CHD pheno-
types carried any mutations.
To help elucidate genetic alterations in affected tissues of
malformed hearts, we have investigated in the past a panel
of cardiac transcription factor genes from the same 68
malformed hearts [16-19,37]. Direct sequencing revealed
mutations in diseased tissues, which were basically absent
in matched normal heart samples. Common occurring
mutations were identified, especially in the binding
domains of transcription factors, which could affect DNA-
protein or protein-protein interactions leading to CHD.
While certain transcription factor genes (NKX2-5, GATA4)
exhibited a high rate of mutations, others were not or
rarely affected (HEY2, MEF2C). Results of these studies
enabled us to put forward a hypothesis of somatic muta-
tions as a novel molecular cause of CHD. Furthermore, we
found malformed hearts containing combination of
mutations in the binding domains of several transcription
factors, As example, we identified in two patients with
AVSD combined mutations in the binding domains of
HEY2, NKX2-5, TBX5 and GATA4 [37]. We also identified
21 patients with combined mutations in the GATA4 zinc
fingers and the homeodomain of NKX2-5 (unpublished
results).
F04AVSD** 11 wk 5 C292R c.+218C>T, c.+259A>G 3
F05AVSD** 10 wk 4 F211L, R229S, Y244C, N285K 4
F08AVSD** 5 mo 5 P226fs 1
F11AVSD** 7 mo 6 C292R c.+77C>T 2
F12AVSD 6 mo 5 R266X 1
F13AVSD** 25 mo 5 C292R 1
F14AVSD** 1 mo 5 T277I, C292R 2
F14aAVSD** 5 wk 5 c.+462T>C 1
F15AVSD 5 d 7 c.+218C>T, c.+259A>G 2
F18AVSD** 7 mo 5 0
F28AVSD 8 yr 3 N273S, L430V 2
F31AVSD** 8 d 6 c.+479A>G 1
F38AVSD 3 mo 4 C292R c.+10T>C, c.+77C>T, c.+280T>C 4
F40AVSD 10 mo 3 c.+44T>A 1
* Heart malformations described earlier in Reamon-Buettner et al. 2004 Am J Pathol 2004, 164:2117–2125.
** Down syndrome
*** nonsynonymous GATA4 mutations in exons 3 and 4 reported earlier in Reamon-Buettner and Borlak 2005, J Med Genet 42:e32; new mutations 
detected in exons 6 and 7 are in bold
Table 3: Spectrum of GATA4 mutations (nonsynonymous and 3'-UTR) in diseased tissues of malformed hearts (Continued)BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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Our malformed hearts were stored in formalin more than
40 years ago and there is speculation about artifacts aris-
ing from this procedure [38-40]. To ensure reliability of
our findings, we investigated sequence variations in 10
formalin-fixed, but healthy hearts which were collected at
the same time as the malformed hearts. Essentially, these
hearts were free of GATA4 mutations, therefore providing
convincing evidence for reliability of the assay. In addi-
tion, our identification of six dbSNPs within the 3'-UTR
demonstrates faithful preservation of DNA and reliability
in using valuable retrospective material with the obvious
advantage of studying clearly defined pathology, as
opposed to using surrogate tissue material distal to organ
defect. Five dbSNPs were highly polymorphic (see Table
2) and were found to be in Hardy-Weinberg equilibrium.
This was confirmed with our control population of
healthy individuals. But cloning of fragments amplified
from diseased heart tissues of patients who were 'hetero-
zygous' for three dbSNPs detected three haplotypes
instead of the expected two, which may be due to duplica-
tion of GATA4 in analyzed tissues.
This result is similar to our previous observations on dif-
ferent cardiac transcription factors conducted on the same
set of malformed hearts [16-19,37]. After cloning ampli-
fied fragments with several closely-spaced 'heterozygous'
mutations as marker loci within a single gene, we
observed several haplotypes in individual hearts, instead
of two haplotypes as expected of a diploid genome. (Note,
we used the term haplotype to define the set of alleles
Effect of mutations in the 3'-UTR of GATA4 on mRNA folding Figure 2
Effect of mutations in the 3'-UTR of GATA4 on mRNA folding. Using the program GeneQuest (Lasergene 6.0), the effect of 
sequence alterations on RNA folding was predicted using the first c.+500 nt in the 3'-UTR of GATA4. GeneQuest uses the 
Vienna RNA folding procedure, taken from Zuker's optimal RNA folding algorithm [43], to fold the sense strand of selected 
DNA regions as RNA. Compared to the reference sequence, 7/9 mutations would result in faulty RNA folding, on which five 
patterns here are shown. Same pattern was observed for c.+10 T > C and c.+44T > A.BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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within an investigated gene locus). The cause of the
observed multiple haplotypes is unknown, but may be
explained by a mixed population of cardiomyocytes carry-
ing different mutations or de novo chromosomal rear-
rangements and gene duplications in the heart tissues of
patients affected by CHD. Our results for NKX2-5 by using
a yeast-based assay to determine function suggest that dif-
ferent haplotypes can lead to different cardiac disease phe-
notypes [41]. Furthermore, the presence of combined
mutant alleles may alter/modify pattern of mRNA folding.
We found, for instance, patients who were either positive
for c.+218C>T or c.+259 A>G or both. Two patients were
heterozygous for both mutations, while one patient was
homozygous for both variant alleles. Singly c.+218C>T or
c.+259 A>G would lead to misfolding (see Fig. 2), but if
combined only the pattern observed for c.+259 A>G
would result. Moreover, different haplotypes due to com-
binations of closely-spaced polymorphisms in the 3'-UTR
of genes can result in different mRNA stabilities in tran-
sient expression assays [35]. Nonetheless, as the mal-
formed hearts were conserved in formalin, possibilities
exist that the observed multiple haplotypes could be PCR
errors resulting from fragmented DNA. We believe the
contrary, however, as specific haplotypes were detected in
several malformed hearts after cloning, but were absent in
matched unaffected heart tissue (unpublished results).
To further support DNA assay reliability on the formalin-
fixed material, we examined in the course of our work
with the Leipzig heart collection, additional genes which
have been associated with cardiac malformations. We
searched for sequence variations affecting the binding
domains of MEF2C and HEY2. In the case of MEF2C gene,
no nonsynonymous mutations have been detected in a
total of 68 patients with complex CHD (unpublished
results). A similar finding was observed with the HEY2
gene, where only three nonsynonymous mutations were
found in 2 of 52 patients [37]. Our work on TBX5 in the
same heart collection likewise supports reliability of using
the material [18]. Mutations in this T-box transcription
factor has been associated with Holt-Oram syndrome
(HOS), a disorder characterized by heart and upper limb
deformities [12]. We amplified 200, 307, 276, 203 and
515 bp containing exons 3, 4, 5, 7 and 8, respectively in
the same heart collection. The sequences encoding the T-
box are located in exons 3, 4 and 5. We found a total of
nine nonsynonymous mutations distributed in few
patients with ASDs and AVSDs. None of the 29 VSDs car-
ried any nonsynonymous mutations, only two synony-
mous mutations were found in two patients. To assess
further method reliability, we investigated in the same
patient cohort amplified fragments from other genes, with
or without prior implication to heart development (e.g.
Table 4: Summary of GATA4 sequence variations in blood samples
Nucleotide change 
NM_002052








1647 c.1129A>G p.Ser377Gly exon 6 rs3729856 10AA:2AG
SYNONYMOU
S
1217 c.699G>A p.Thr233 exon 3 1 (GA)
3'-UTR
1967 c.+119A>T exon 7 2 (AT)
3107 c.+1260G>A exon 7 1 (GA)
2201 c.+354A>C exon 7 rs867858 3AA:9AC 53AA:36AC:11CC
2273 c.+426C>T exon 7 rs1062219 1CC:8CT:3TT 39CC:38CT:23TT
2364 c.+517T>C exon 7 rs884662 4TT:5CT:3CC 43TT:30CT:27CC
2379 c.+532T>C exon 7 rs904018 1TT:5CT: 6CC 30TT: 30CT:40CC
2410 c.+563C>G exon 7 rs12825 8CC:3CG:1GG 69CC:11CG:20GG
2434 c.+587A>G exon 7 rs804291 12GG 100 GG
3005 c.+1158C>T exon 7 rs11785481 7CC:5CT
3103 c.+1256A>T exon 7 rs12458 3AA:9AT
3202 c.+1355G>A exon 7 rs1062270 11GG:1AG
3368 c.+1521G>C exon 7 rs3293358 5CC:6CG:1GG
INTRONIC
c.-518-25C>T intron 2 (1CT:1TT)
c.-458+5A>G intron 1 (AG)
c.783+16G>A intron 1 (GA)
c.614-61G>C intron rs10503425 8GG:3CG:1CC 27AA:12AC:3CC
c.997+56A>C intron rs804280 3AA:7AC:2CCBMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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CFC1, HMGN4 and BRCC2), in the same heart collection,
as well as in formalin-fixed normal mouse heart s (e.g.
Hand1, Nkx2-5 and  Gata4)  but did not find sequence
alterations [37].
Conclusion
We identified hotspots associated with cardiac defects in
the 3'-UTR region. Our results suggest that somatic GATA4
mutations in the 3'-UTR may provide an additional
molecular rationale for CHD
Methods
Materials, genomic DNA isolation, and mutation detec-
tion have been described previously [16]. Briefly, we ana-
lyzed 68 formalin-fixed hearts of Caucasians with
complex cardiac malformations, notably n = 29 with ven-
tricular (VSD), n = 16 with atrial (ASD), and n= 23 with
atrioventricular (AVSD) septal defects. The explanted
hearts, which were collected between 1954–1982, were
obtained from the Institute of Anatomy, University of
Leipzig, Germany. We also analyzed blood samples of 12
Caucasian patients with CHD, and blood samples of 100
unrelated healthy Caucasian individuals. In blood sam-
ples, defects of patients with CHD included VSD, ASD,
hypoplastic left heart syndrome (HLHS), transposition of
the great arteries (TGA), sub-pulmonary stenosis (SPS)
and heterotaxy. Except for two patients who came from
the same family, 10/12 patients were unrelated individu-
als. In the formalin-fixed malformed hearts, diseased tis-
sues in the vicinity of the septal defects were analyzed.
Detection of 3'-UTR mutations in blood samples of patients with CHD Figure 3
Detection of 3'-UTR mutations in blood samples of patients with CHD. (A) sequence electropherograms for c.+119A>T, 
showing heterozygous (AT) and homozygous (AA) genotypes; (B) in a family of four in which the two children had ASD; the 
father and the children had the heterozygous genotype AT (+), the mother was homozygous for the reference allele AA; (C) 
Compared to the reference sequence and on the basis of Vienna RNA folding procedure, c.+119A>T is predicted to affect 
RNA folding.BMC Medical Genetics 2007, 8:38 http://www.biomedcentral.com/1471-2350/8/38
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Matched healthy heart tissues were likewise investigated
for sequence alterations. Materials used in this study were
obtained in accordance to an approved protocol. JB has
obtained approval to conduct genetic studies involving
human materials from the Medical School Hannover. The
formalin-fixed hearts were collected more than 40 years
ago and cadavers were donated voluntarily by patients'
relatives.
The primers and PCR conditions used in investigating
sequence variations of GATA4 are given in Table 1. PCR-
amplified fragments were sequenced directly using
BigDyeTerminator v3.1 Kit (Applied Biosystems, Darm-
stadt, Germany) and Applied Biosystems 3100 Genetic
Analyzer. Sequences were analyzed using SeqScape 2.0
(Applied Biosystems) or DNASTAR Lasergene 6.0 (Madi-
son, Wisconsin USA). The numbering of mutations
within the coding region of GATA4 starts with nucleotide
A of the first codon ATG, while that in the untranslated
region was based on NM_002052. Nucleotide changes in
the untranslated and intronic regions were numbered
according to suggested nomenclature [24]. Sequence vari-
ations were verified by independent PCR, double-strand
sequencing, PCR-RFLP, or cloning of heterozygous geno-
types followed by subsequent sequencing of clones,
allowing the identification of variant alleles. Unless
reported as NCBI dbSNPs, we refer to nucleotide changes
as sequence variations or mutations interchangeably,
which simply means deviations from the reference GATA4
sequence (NM_002052), and disease-causing or not.
Abbreviations
CHD Congenital heart disease
ASD Atrial septal defect
VSD Ventricular septal defect
AVSD Atrioventricular septal defect
UTR Untranslated region
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